BIAS
Beacon Investment Advisory Services Portfolio holdings
AUM
$2.27B
1-Year Return
12.42%
This Quarter Return
-2.97%
1 Year Return
+12.42%
3 Year Return
+67.44%
5 Year Return
+99.24%
10 Year Return
+207.8%
AUM
$2.14B
AUM Growth
-$169M
(-7.3%)
Cap. Flow
-$67.7M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
32.23%
Holding
255
New
6
Increased
87
Reduced
108
Closed
19
Top Buys
| 1 |
Morgan Stanley
MS
|
+$7.35M |
| 2 |
Apollo Global Management
APO
|
+$4.33M |
| 3 |
Accenture
ACN
|
+$4.02M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.05M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.9M |
Top Sells
| 1 |
DexCom
DXCM
|
+$9.63M |
| 2 |
Insulet
PODD
|
+$7.59M |
| 3 |
T Rowe Price
TROW
|
+$7.5M |
| 4 |
Idexx Laboratories
IDXX
|
+$6.02M |
| 5 |
Danaher
DHR
|
+$5.62M |
Sector Composition
| 1 | Healthcare | 19.76% |
| 2 | Technology | 19.38% |
| 3 | Financials | 10.88% |
| 4 | Consumer Discretionary | 8.07% |
| 5 | Industrials | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ares Management
ARES
$40.2B
| $641K | 0.03% |
4,375
| – | – |
|
152
Deere & Co
DE
$128B
| $628K | 0.03% |
1,339
-94
| -7% | -$44.1K |
|
153
Verizon
VZ
$185B
| $608K | 0.03% |
13,413
-372
| -3% | -$16.9K |
|
154
Schwab US Large- Cap ETF
SCHX
$60.3B
| $581K | 0.03% |
26,330
+1,731
| +7% | +$38.2K |
|
155
CME Group
CME
$94B
| $581K | 0.03% |
2,190
-155
| -7% | -$41.1K |
|
156
Amphenol
APH
$144B
| $576K | 0.03% |
8,778
+74
| +0.9% | +$4.85K |
|
157
Pultegroup
PHM
$27B
| $570K | 0.03% |
5,544
| – | – |
|
158
Novartis
NVS
$239B
| $569K | 0.03% |
5,103
-2,094
| -29% | -$233K |
|
159
AstraZeneca
AZN
$246B
| $548K | 0.03% |
7,450
+439
| +6% | +$32.3K |
|
160
Vanguard Mid-Cap ETF
VO
$88.1B
| $518K | 0.02% |
2,002
-50
| -2% | -$12.9K |
|
161
Loews
L
$20.2B
| $515K | 0.02% |
5,598
| – | – |
|
162
Nike
NKE
$107B
| $498K | 0.02% |
7,845
-3
| -0% | -$190 |
|
163
M&T Bank
MTB
$31B
| $495K | 0.02% |
2,768
| – | – |
|
164
Dollar General
DG
$22.9B
| $493K | 0.02% |
+5,611
| New | +$493K |
|
165
Texas Pacific Land
TPL
$21.5B
| $493K | 0.02% |
372
| – | – |
|
166
Bristol-Myers Squibb
BMY
$95.1B
| $492K | 0.02% |
8,063
+212
| +3% | +$12.9K |
|
167
Jacobs Solutions
J
$17.6B
| $486K | 0.02% |
4,060
| – | – |
|
168
Coca-Cola
KO
$290B
| $470K | 0.02% |
6,568
-603
| -8% | -$43.2K |
|
169
JPMorgan Diversified Return US Equity ETF
JPUS
$391M
| $470K | 0.02% |
4,077
| – | – |
|
170
Solventum
SOLV
$12.8B
| $463K | 0.02% |
6,083
+31
| +0.5% | +$2.36K |
|
171
Alnylam Pharmaceuticals
ALNY
$61.2B
| $456K | 0.02% |
1,688
-2,033
| -55% | -$549K |
|
172
Arch Capital
ACGL
$34.5B
| $439K | 0.02% |
4,564
-283
| -6% | -$27.2K |
|
173
Viatris
VTRS
$11.6B
| $437K | 0.02% |
50,185
+13,568
| +37% | +$118K |
|
174
Altria Group
MO
$111B
| $422K | 0.02% |
7,024
+1,037
| +17% | +$62.2K |
|
175
Micron Technology
MU
$176B
| $415K | 0.02% |
4,781
-1,510
| -24% | -$131K |
|